Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Heart transplantation].

Alain Pavie1, Nicolas Bonnet, Pascal Leprince

  • 1Institut de cardiologie, groupe hospitalier La Pitié-Salpêtrière, université Pierre-et-Marie-Curie, Paris-6, 75651 Paris 13. alain.pavie@psl.aphp.fr

La Revue Du Praticien
|June 21, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The gut-bone axis: microbial metabolism and nutritional interventions for bone health.

Gut microbes·2026
Same author

A report on the successful sparing of the entire anterior mitral leaflet through the implementation of a customized procedure in the context of mitral valve replacement.

Journal of cardiothoracic surgery·2026
Same author

A young child formula with Limosilactobacillus reuteri and GOS modulates gut microbiome and enhances bone and muscle development: a randomized trial.

Nature communications·2025
Same author

A Frozen Elephant Trunk Technique to Reduce Circulatory Arrest Time in Hybrid Aortic Arch for Acute Aortic Dissection: Early and Midterm Outcomes in a Multicentric Cohort of 153 Patients.

Annals of surgery·2025
Same author

Anaesthetic depth and short-term delirium after cardiac surgery intervention: the study protocol of the BISCAR multicentre randomised clinical trial.

BMJ open·2025
Same author

Effective percutaneous treatment of a subacute left internal mammary artery perforation and pseudoaneurysm after coronary artery bypass grafting: a case report.

European heart journal. Case reports·2025
Same journal

[Prolonged fever].

La Revue du praticien·2026
Same journal

[Lower gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[Management of antiplatelet agents and oral anticoagulants in cases of gastrointestinal bleeding].

La Revue du praticien·2026
Same journal

[A history of child abuse intervention in the West].

La Revue du praticien·2026
Same journal

[Agranulocytose médicamenteuse].

La Revue du praticien·2026
Same journal

[Patient education in heart failure].

La Revue du praticien·2026
See all related articles

Heart transplantation is the leading treatment for end-stage heart failure, with improved immunosuppression reducing acute rejection. However, chronic rejection remains a significant long-term challenge for heart transplant recipients.

Area of Science:

  • Cardiology
  • Transplantation Medicine
  • Immunology

Background:

  • Heart transplantation is the optimal therapy for end-stage heart failure.
  • Ischemic and idiopathic cardiomyopathies are primary indications for heart transplant.
  • Contraindications include risks associated with immunosuppression and fixed pulmonary hypertension.

Purpose of the Study:

  • To review the current status of heart transplantation.
  • To highlight key outcomes including rejection rates and patient survival.
  • To identify major challenges in long-term heart transplant management.

Main Methods:

  • Clinical evaluation of patients for heart transplantation eligibility.
  • Inclusion on a waiting list managed by the French Biomedicine Agency.

Related Experiment Videos

  • Monitoring of acute and chronic rejection post-transplant.

    • Main Results:

    • Severe acute rejection incidence is 5% due to improved immunosuppression.
    • Chronic rejection affects 40-50% of patients by 5 years, posing a major mortality risk.
    • One-year survival is 80%, with 5-year and 10-year survival rates at 65% and 50% respectively.

    Conclusions:

    • Heart transplantation offers significant survival benefits for end-stage heart failure patients.
    • Advances in immunosuppression have reduced acute rejection rates.
    • Chronic rejection remains the primary obstacle to long-term graft survival and patient longevity.